IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,661,000 | -84.3% | 2,047,180 | -55.6% | 0.01% | -81.2% |
| Q4 2020 | $16,914,000 | +71.5% | 4,608,786 | 0.0% | 0.06% | +64.1% |
| Q3 2020 | $9,863,000 | +19.6% | 4,608,786 | 0.0% | 0.04% | +8.3% |
| Q2 2020 | $8,250,000 | +35.6% | 4,608,786 | 0.0% | 0.04% | -2.7% |
| Q1 2020 | $6,084,000 | -27.5% | 4,608,786 | 0.0% | 0.04% | -17.8% |
| Q4 2019 | $8,388,000 | -37.0% | 4,608,786 | 0.0% | 0.04% | -50.5% |
| Q3 2019 | $13,319,000 | +8.3% | 4,608,786 | +0.1% | 0.09% | +8.3% |
| Q2 2019 | $12,298,000 | -0.4% | 4,605,822 | -4.8% | 0.08% | +6.3% |
| Q1 2019 | $12,342,000 | -7.9% | 4,839,895 | +0.1% | 0.08% | -28.2% |
| Q4 2018 | $13,396,000 | -68.9% | 4,836,237 | +0.0% | 0.11% | -61.3% |
| Q3 2018 | $43,070,000 | -15.6% | 4,833,897 | -87.5% | 0.28% | -25.8% |
| Q2 2018 | $51,024,000 | – | 38,654,811 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |